Cassia aubrevillei
Cassia aubrevillei · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Cassia aubrevillei is a botanical species recognized for its significant therapeutic potential in traditional medicine. The plant contains the active chemical compound known as chrysophanic acid, which contributes to its biological efficacy. Researchers utilize both alcoholic and aqueous extracts to harness the medicinal properties found within its tissues. These preparations are specifically studied for their ability to address medical conditions such as onchocerciasis. Furthermore, the plant offers relief for symptoms like pruritus, making it a subject of interest for dermatological health.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Taxonomy
Cassia aubrevillei belongs to the vast kingdom Plantae, marking its place among the diverse world of botanical life. Within this kingdom, the species is classified under the class Equisetopsida. It further falls into the order Fabales, a group that helps define its evolutionary lineage. As a member of the family Fabaceae, it shares characteristics with many well-known legumes. Ultimately, this plant is categorized under the specific genus Cassia, which distinguishes its unique biological identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Cassia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cassia aubrevillei is a notable botanical species primarily found across the diverse landscapes of the African continent. Its natural distribution spans several key regions within West Tropical Africa, including Guinea, Liberia, and the Ivory Coast. The plant also extends its reach into West-Central Tropical Africa, establishing a presence in nations such as Gabon. Furthermore, it can be located within the Central African Republic, showcasing its adaptability to varied environments. This widespread geographical range highlights the ecological importance of the species throughout these tropical territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cassia aubrevillei grows in a distinct tree form, establishing a presence within its natural habitat. As a self-supporting species, it maintains its own structure without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Cassia aubrevillei is a significant medicinal plant used traditionally in Liberia to treat onchocerciasis. Known locally as "Ganna Ganna," the bark of this tree is prepared into extracts that offer potential therapeutic benefits. Scientific investigations have identified chrysophanic acid as a key anthraquinone component within the plant's chemical profile. This specific compound has demonstrated strong in vitro microfilaricidal activity, contributing to the plant's medicinal properties. Consequently, these findings suggest that the species could serve as a valuable adjuvant in managing the symptoms of the disease.
Conditions
Cassia aubrevillei, known traditionally as "Ganna Ganna," serves as a medicinal resource for treating onchocerciasis. The plant's extracts demonstrate a capacity to treat microfilaria (mf) density, with alcoholic extracts successfully killing mf in vitro within 24 hours. Clinical observations indicate that the plant can significantly reduce mf counts in certain patients. Furthermore, the application of Cassia aubrevillei effectively treats pruritus, providing patients with a rapid decline in itching that lasts for several months. These combined properties suggest the plant holds promise as a useful adjuvant in the ongoing therapy of onchocerciasis.
Preparations
Cassia aubrevillei is utilized in the preparation of both aqueous and alcoholic extracts to treat onchocerciasis. The bark of the plant is used to create an aqueous extract based on traditional knowledge from local people in Liberia. While the aqueous version was studied for its effects on microfilaria density and pruritus, the alcoholic extract demonstrated superior in vitro results. Specifically, the alcoholic extract proved highly effective by killing microfilaria within 24 hours at specific concentrations. These different extraction methods highlight the plant's potential as a medicinal adjuvant through both aqueous and alcoholic forms.